Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jan;95(4):e2566.
doi: 10.1097/MD.0000000000002566.

Association Between Leptin (-2548G/A) Genes Polymorphism and Breast Cancer Susceptibility: A Meta-Analysis

Affiliations
Review

Association Between Leptin (-2548G/A) Genes Polymorphism and Breast Cancer Susceptibility: A Meta-Analysis

Wanjun Yan et al. Medicine (Baltimore). 2016 Jan.

Erratum in

Abstract

Leptin is a confirmed breast cancer susceptibility gene. However, published studies reported mixed results. This meta-analysis was conducted to systematically get a more accurate estimation of the association between the Leptin (-2548G/A) gene polymorphism and breast cancer risk. To assess the effect of Leptin (-2548G/A) gene polymorphism on breast cancer susceptibility, we searched PUBMED, ISI Web of Knowledge, EMBASE, Chinese National Knowledge Infrastructure (CNKI) databases until September 2015 to identify eligible studies, without restriction. Summary odds ratios (ORs) and 95% confidence intervals (CIs) were used to evaluate the susceptibility to breast cancer. Separate analyses were conducted on features of the population such as ethnicity, source of controls, and country. A total of 9 case-control studies on Leptin (-2548G/A) gene polymorphism and breast cancer risk, including 3725 cases and 3093 case-free controls were identified. The results revealed that compared with the G allele, the A allele was associated with modestly increased risk of overall breast cancer (A vs G: OR = 1.12, 95%CI = 1.04-1.20, P = 0.002, Phet P < 0.00001). Following further stratified analyses, in the subgroup analyses by ethnicity, a significantly increased risk was observed among Caucasian (A vs G: OR = 1.11, 95%CI = 1.03-1.20, P = 0.006, Phet = 0.00001). No publication bias was found in the present study. In conclusion, our meta-analysis suggests that the Leptin (-2548G/A) gene polymorphism plays an important role in breast cancer susceptibility, especially in Caucasian.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

FIGURE 1
FIGURE 1
Flowchart of study selection. CNKI = Chinese National Knowledge Infrastructure.
FIGURE 2
FIGURE 2
Forest plots of Leptin (-2548G/A) gene polymorphism and breast cancer risk in the overall population (AA + GA vs GG). The squares and horizontal lines correspond to the study-specific OR and 95% CI. The area of the squares reflects the weight (inverse of the variance). The diamond represents the summary OR and 95% CI.CI = confidence interval, OR = odds ratio.
FIGURE 3
FIGURE 3
Forest plots of Leptin (-2548G/A) gene polymorphism and breast cancer risk in the Asian and Caucasian population (AA + GA vs GG). The squares and horizontal lines correspond to the study specific OR and 95% CI. The area of the squares reflects the weight (inverse of the variance). The diamond represents the summary OR and 95% CI.CI = confidence interval, OR = odds ratio.
FIGURE 4
FIGURE 4
Funnel plot assessing evidence of publication bias from 9 studies (AA + GA vs GG).

Similar articles

Cited by

References

    1. Siegel R, Naishadham D, Jemal A, et al. Cancer statistics, 2013. CA Cancer J Clin 2013; 63:11–30. - PubMed
    1. Lo PK, Sukumar S. Epigenomics and breast cancer. Pharmacogenomics 2008; 9:1879–1902. - PMC - PubMed
    1. Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000; 343:78–85. - PubMed
    1. Hulka BS, Moorman PG. Breast cancer: hormones and other risk factors. Maturitas 2001; 38:103–113. - PubMed
    1. Zhao E, Cui D, Yuan L, et al. MDM2 SNP 309 polymorphism and breast cancer risk: a meta-analysis. Mol Biol Rep 2012; 39:3471–3477. - PubMed